KYMERA THERAPEUTICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 202[•] Senior Debt SecuritiesIndenture • October 1st, 2021 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
INDENTURE, dated as of [•], 202[•], among KYMERA THERAPEUTICS, INC., a Delaware corporation (the “Company”), and [TRUSTEE] as trustee (the “Trustee”):
KYMERA THERAPEUTICS, INC. COMMON STOCK SALES AGREEMENTSales Agreement • October 1st, 2021 • Kymera Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Kymera Therapeutics, Inc. (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows:
